Niraj Ramachandran | Senior Director - Cell and Gene Therapy (CMC)
Genentech

Niraj Ramachandran, Senior Director - Cell and Gene Therapy (CMC), Genentech

Strategic Regulatory CMC Leader with extensive expertise in Cell & Gene Therapies (CGT), biologics, and tissue engineering. Proven track record of navigating the transition from early-phase development to commercial lifecycle management. Expert at authoring robust BLA/MAA/IND submissions and leading high-stakes health authority negotiations. A collaborative leader focused on mitigating risk, ensuring supply chain continuity, and driving complex global projects to completion on time and within budget.

Appearances:



Advanced Therapies USA 2026 - Day 2 @ 14:05

Panel Discussion: Manufacturing Strategies: Decentralised Vs. Centralised Approaches for Cell Therapies

Advanced Therapies USA 2026 - Day 2 @ 15:20

CMC regulatory strategy for potency assays for cell and gene therapies

last published: 15/May/26 11:35 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+02034332221